Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial

By afschroeder • January 23, 2026

Files DC, Matthay MA, Ware LB, Brower RG, Aggarwal NR, Brown SM, Chang SY, Douglas IS, Duggal A, Gibbs KW, Fields S, Foulkes AS, Ginde A, Goodwin A, Harris ES, Hendey GW, Hibbert K, Hite RD, Hough CL, Huang W, Khan A, Lai P, Liu KD, Miller C, Moskowitz A, Riker R, Robinson BRH, Self WH, Tidswell MA, Yealy DM, Thompson BT, Fowler AA. Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial. CHEST Crit Care. 2025 Sep;3(3):100168. doi: 10.1016/j.chstcc.2025.100168. Epub 2025 Aug 26. PMID: 41574117; PMCID: PMC12823136.

Tags: antioxidant, Lung injury, Publications, Pulmonary, Critical Care & Sleep Medicine, Vitamin C

Related Posts

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction

Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra[...]